<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03791320</url>
  </required_header>
  <id_info>
    <org_study_id>FASTII Study: June 26, 2018</org_study_id>
    <nct_id>NCT03791320</nct_id>
  </id_info>
  <brief_title>Fast Assessment of STenosis Severity- FASTII Study</brief_title>
  <acronym>FASTII</acronym>
  <official_title>Multicenter Validation of 3D-QCA Based FFR vs. Pressure Wire Based FFR: The FAST-II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tokyo Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Cardiologico Monzino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Carl Gustav Carus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Multicenter FAST (Fast Assessment of STenosis severity) study is a prospective
      observational multicenter study designed to evaluate the diagnostic accuracy of offline
      3D-QCA based FFR, using CAAS Workstation (Pie Medical Imaging, Maastricht, the Netherlands)
      in identifying hemodynamically significant coronary artery disease with pressure wire-based
      FFR (≤0.80) as the reference standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Multicenter FAST study is a prospective observational multicenter international study in
      which offline computation of vFFR is compared to conventional invasive, wire based FFR
      measurements. Pressure wire based FFR will be performed in patients with at least one
      intermediate coronary lesion at the discretion of the operator (typically defined as a
      coronary artery lesion with a diameter stenosis of 30-70% by visual assessment). A total of 3
      two-dimensional angiography images, will be recorded and exported to the CAAS workstation 8.0
      (Pie Medical Imaging, Maastricht, the Netherlands): two orthogonal views to create a 3D
      reconstruction of the coronary arteries and one view to ascertain the position of the FFR
      pressure wire. vFFR will be calculated automatically, by using the invasively measured aortic
      root pressure. vFFR measurements will be performed online by the different centers. In
      addition, all angiographic imaging data will be sent to an independent core laboratory
      (Cardialysis, Rotterdam, The Netherlands) for offline analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of vFFR to identify FFR (≤0.8 or &gt;0.8) calculated by corelab</measure>
    <time_frame>1 year</time_frame>
    <description>The diagnostic accuracy of offline vFFR assessed by a blinded independent core laboratory to identify hemodynamically-significant coronary stenosis with FFR (≤0.8 or &gt;0.8) as the reference standard.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of vFFR to identify FFR (≤0.8 or &gt;0.8) calculated by site/operator</measure>
    <time_frame>1 year</time_frame>
    <description>The diagnostic accuracy of operator or cathlab technician calculated online vFFR to identify hemodynamically-significant coronary stenosis with FFR (≤0.8 or &gt;0.8) as the reference standard.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interobserver variability</measure>
    <time_frame>1 year</time_frame>
    <description>3D-QCA based FFR (vFFR) will be calculated twice: by the operator/technician of different centers AND by an independent corelab (Cardoalysis). Correlation and agreement between these two measurements will be assessed in order to investigate the Inter-observer variability.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vessel Fractional Flow Reserve</intervention_name>
    <description>FFR measurement based on coronary angiography</description>
    <other_name>3D-QCA based FFR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients ≥ 18 years presenting with stable or unstable angina or non-ST elevation acute
        coronary syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients ≥ 18 years

          -  indication procedure: stable, unstable angina or non-ST elevation acute coronary
             syndrome

          -  Diagnostic coronary angiography or PCI with an indication to perform re-PCI FFR
             assessment of at least one coronary artery lesion.

        Exclusion Criteria:

          -  ST-elevation myocardial infarction (STEMI)

          -  Cardiogenic shock

          -  Severe hemodynamic instability

          -  Adenosine intolerance

          -  Lesions containing thrombus, left main lesions, grafts, arteries with collaterals
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joost Daemen, MD;PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joost Daemen, MD;PhD.</last_name>
    <phone>+31 10 703 5260</phone>
    <email>j.daemen@erasmusmc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kaneshka Masdjedi, MD</last_name>
    <phone>+31 10 703 5260</phone>
    <email>k.masdjedi@erasmusmc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ziad Ali, MD;PhD</last_name>
    </contact>
    <contact_backup>
      <email>zaa2112@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Van Belle, MD;PhD</last_name>
    </contact>
    <contact_backup>
      <email>Eric.VANBELLE@CHRU-LILLE.FR</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Axel Linke, MD;PhD</last_name>
    </contact>
    <contact_backup>
      <email>axel.linke@tu-dresden.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Bartorelli, MD;PhD</last_name>
    </contact>
    <contact_backup>
      <email>antonio.bartorelli@cardiologicomonzino.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical University</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nobuhiro Tanaka, MD;PhD</last_name>
      <email>n-tanaka@tokyo-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joost Daemen, MD;PhD</last_name>
    </contact>
    <contact_backup>
      <email>j.daemen@erasmusmc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>December 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2019</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Joost Daemen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Fractional Flow Reserve</keyword>
  <keyword>Coronary Physiology</keyword>
  <keyword>3D-QCA</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data are needed for the final analysis which will be done by Erasmus MC.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

